SCHEMBL17653961

SCHEMBL17653961

FC(F)(F)CN1CCc2cc(Br)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.47
▸ ABHD6 Q9BV23 3/20 0.46
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ HSD17B3 P37058 1/20 0.38
▸ SLC22A12 Q96S37 1/20 0.38
▸ SRD5A1 P18405 1/20 0.38
▸ S1PR1 P21453 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14243009 0.87 HTR2A (0.56) ARABHD6CYP1A2CYP3A4CYP2D6
SCHEMBL16620172 0.81 AR (0.52) ARABHD6CYP1A2CYP3A4CYP2D6
SCHEMBL29644814 0.79 PRMT5 (0.45) HDAC1HDAC8SRD5A1
SCHEMBL27401081 0.78 HDAC1 (0.42) ARHDAC1HDAC8HDAC6S1PR1
SCHEMBL27401083 0.78 S1PR1 (0.46) ARHTR2AHTR2CHTR2BS1PR1
SCHEMBL12509817 0.78 HSD17B3 (0.55) ARABHD6CYP1A2CYP3A4CYP2D6
SCHEMBL28266707 0.76 ALDH1A1 (0.63) ARMEN1USP2ALDH1A1CDK4
SCHEMBL21577668 0.75 CYP1A2 (0.47) ARABHD6CYP1A2CYP3A4CYP2D6
SCHEMBL21469180 0.75 ALDH1A1 (0.47) ARABHD6CYP1A2CYP3A4CYP2D6
SCHEMBL9901142 0.74 HDAC1 (0.43) ARABHD6CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024117179-A1 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF ALIVEXIS, INC. (JP) 2024-06-06 — — WO disclosed
WO-2024117179-A1 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF ALIVEXIS, INC. (JP) 2024-06-06 — — WO disclosed
WO-2016051193-A1 COMPOUNDS USEFUL AS CSF1 MODULATORS REDX PHARMA PLC (GB) 2016-04-07 — — WO disclosed
WO-2016051193-A1 COMPOUNDS USEFUL AS CSF1 MODULATORS REDX PHARMA PLC (GB) 2016-04-07 — — WO disclosed
Send feedback